DI BONA, DANILO
 Distribuzione geografica
Continente #
NA - Nord America 4.941
EU - Europa 2.560
AS - Asia 2.427
SA - Sud America 942
Continente sconosciuto - Info sul continente non disponibili 565
AF - Africa 78
OC - Oceania 3
Totale 11.516
Nazione #
US - Stati Uniti d'America 4.778
SG - Singapore 935
BR - Brasile 736
RU - Federazione Russa 639
DE - Germania 493
CN - Cina 462
VN - Vietnam 403
HK - Hong Kong 300
IE - Irlanda 286
IT - Italia 240
FI - Finlandia 234
FR - Francia 199
UA - Ucraina 121
SE - Svezia 99
GB - Regno Unito 94
AR - Argentina 84
CA - Canada 71
BD - Bangladesh 68
ID - Indonesia 54
IN - India 43
CZ - Repubblica Ceca 41
MX - Messico 41
EC - Ecuador 39
TR - Turchia 33
ZA - Sudafrica 24
CO - Colombia 21
AT - Austria 19
IQ - Iraq 16
PK - Pakistan 16
PY - Paraguay 16
VE - Venezuela 16
BE - Belgio 15
JP - Giappone 13
MA - Marocco 13
NL - Olanda 12
ES - Italia 11
LT - Lituania 11
PE - Perù 11
PL - Polonia 11
CL - Cile 9
JM - Giamaica 9
SA - Arabia Saudita 9
TN - Tunisia 9
AL - Albania 7
CR - Costa Rica 7
KZ - Kazakistan 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
UZ - Uzbekistan 6
AM - Armenia 5
CI - Costa d'Avorio 5
DZ - Algeria 5
JO - Giordania 5
KE - Kenya 5
NI - Nicaragua 5
NP - Nepal 5
SV - El Salvador 5
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
IL - Israele 4
LB - Libano 4
PH - Filippine 4
PR - Porto Rico 4
SY - Repubblica araba siriana 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EG - Egitto 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
MY - Malesia 3
PT - Portogallo 3
RS - Serbia 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
EE - Estonia 2
GR - Grecia 2
KG - Kirghizistan 2
KR - Corea 2
LK - Sri Lanka 2
LY - Libia 2
NO - Norvegia 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
AO - Angola 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
DJ - Gibuti 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GN - Guinea 1
HR - Croazia 1
Totale 10.930
Città #
San Jose 1.297
Dallas 574
Ashburn 553
Munich 415
Singapore 363
Hong Kong 298
Dublin 284
Helsinki 204
Santa Clara 191
Council Bluffs 183
Columbus 170
Lauterbourg 149
Beijing 148
Ho Chi Minh City 139
New York 91
Hanoi 81
Jacksonville 78
Los Angeles 77
Moscow 72
Phoenix 65
Chandler 54
Nyköping 53
São Paulo 53
The Dalles 52
Seattle 47
Dearborn 45
Hudson 44
London 32
Boardman 28
Nanjing 28
Princeton 28
Atlanta 27
San Francisco 27
Dong Ket 26
Brno 25
Brooklyn 25
Foggia 24
Frankfurt am Main 23
North Bergen 22
Haiphong 21
Mexico City 21
Assago 20
Brasília 20
Montreal 19
Curitiba 18
Rome 18
Chicago 17
Denver 17
Orem 17
Wilmington 17
Bari 16
Boston 16
Olomouc 16
Guayaquil 15
Milan 15
Nuremberg 15
Toronto 15
Brussels 14
Rio de Janeiro 14
Biên Hòa 13
Johannesburg 13
Jyväskylä 13
Dhaka 12
Tokyo 12
Da Nang 11
Guangzhou 11
Hebei 11
Belo Horizonte 10
Can Tho 10
Jiaxing 10
Porto Alegre 10
Quito 10
Warsaw 10
Agrolândia 9
Buffalo 9
Hải Dương 9
Jakarta 9
Murrysville 9
Nanchang 9
Ninh Bình 9
Queens 9
Salvador 9
Vienna 9
Ankara 8
Buenos Aires 8
Campinas 8
Chennai 8
Falkenstein 8
Houston 8
Osasco 8
Shenyang 8
Stevenage 8
Thái Bình 8
Wuhan 8
Asunción 7
Charlotte 7
Fortaleza 7
Joinville 7
Kingston 7
Miami 7
Totale 6.812
Nome #
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 758
ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025 340
Allergic adverse events following immunization: Data from post-marketing surveillance in Apulia region (South of Italy) 231
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 219
Association between the interleukin-1β polymorphisms and Alzheimer's disease: A systematic review and meta-analysis 200
An Update on Nonsteroidal Anti-Inflammatory Drug-Induced Urticaria 152
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 118
Immunological characterization of onion (Allium cepa) allergy 116
Wasp immunotherapy induces a long term and IgG4-independent protection. 115
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects 111
Desensitization in Iron Product Allergy 111
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study 105
A desensitization protocol for delayed allergy to cytarabine: Analysis of two cases 102
Cost-effectiveness of grass pollen allergen immunotherapy in adults 100
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 98
Dermanyssosis in the Urban Context: When the One Health Paradigm Is Put into Practice 97
Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. 97
Wasp immunotherapy induced long-term and IgG4-independent protection 95
ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025 95
[Cytomegalovirus infection in immunocompetent patients. Clinical and immunological considerations] 95
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study 95
Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis. A systematic review and meta-analysis. 89
Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera) 89
Omalizumab in long-term treatment of refractory chronic spontaneous urticaria: effects of discontinuation. 87
An interpretable cluster-based logistic regression model, with application to the characterization of response to therapy in severe eosinophilic asthma 85
La disfunzione psicosomatica delle corde vocali 82
Insulin/IGF-1 Signaling: More than a Metabolic Pathway 81
Delayed allergy to acyclovir revealed by lymphocyte proliferation test 81
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 80
Reazioni ritardate a farmaci: dal test di proliferazione linfocitaria alla desensibilizzazione 79
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 78
Omalizumab nell'orticaria cronica spontanea: uno studio real-life su 14 pazienti 77
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 77
Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: A case report 77
A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma 76
Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis–based comparison 75
Studi su Omalizumab nella terapia dell'asma severo. Valutazione degli effetti sulla risposta immunologica IgE in vivo. Valutazione della tollerabilità 73
Omalizumab in long-term treatment of refractory chronic spontaneus urticaria:effects of discontinuation 73
Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review 73
Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population 73
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study 72
Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis 72
Importance of Specific IgE/Total IgE Ratio in Disambiguating Amoxicillin Allergy Diagnosis in a Real-Life Setting 71
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management 71
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response 70
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 70
Association between interleukin-10 polymorphisms and alzheimer's disease: A systematic review and meta-analysis 69
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis 69
Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome 69
[Role of combination NK/KIRs in the natural history of viral infections.] 67
Association between genetic variations in the insulin/insulin-like growth factor (Igf-1) signaling pathway and longevity: a systematic review and meta-analysis 67
Allergic contact dermatitis from vitamins: A systematic review 67
Two-year follow-up after drug desensitization in mucopolysaccharidosis 67
Association of klotho polymorphisms with healthy aging: A systematic review and meta-analysis 66
Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: A systematic review and meta-analysis 66
Severe asthma and personalized approach in the choice of biologic 66
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 65
Chronic urticaria reveals JAK2V617F positive essential thrombocythemia 64
Desensitization in Iron Product Allergy 63
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis 63
Targeting aging with functional food: Pasta with opuntia single-arm pilot study 63
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 62
Efficacy and safety of allergen immunotherapy in patients with allergy to molds: A systematic review 62
Systematic review by meta-analyses on the possible role of TNF-α polymorphisms in association with Alzheimer's disease 61
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 61
Biologics in severe asthma: the role of real-world evidence from registries 60
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2‐year real‐life study 60
Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine 60
Role of immunogenetics in the outcome of HCMV infection: Implications for ageing 60
In Vivo and In Vitro Assessment and Proteomic Analysis of the Effectiveness of Physical Treatments in Reducing Allergenicity of Hazelnut Proteins 59
Efficacy of index of reactivity-liquid sublingual immunotherapy in allergic rhinoconjunctivitis: a systematic review and meta-analysis of randomized studies 58
The impact of antiviral treatments on the course of chronic hepatitis C: An evidence-based approach 57
Latex Allergy – From Discovery to Component-resolved Diagnosis 56
The Role of Immunogenetics in COVID-19 56
Inflammation, genes and zinc in Alzheimer's disease 56
Polymorphisms of pro-inflammatory genes and prostate cancer risk: A pharmacogenomic approach 55
Effect of Peginterferon Alfa-2a on Liver Histology in Chronic Hepatitis C: A Meta-analysis of Individual Patient Data 55
Translation of basic research into clinics: Killer immunoglobulin-like receptors genes in autoimmune and infectious diseases 55
HLA and KIR Interaction in Patients with Ischemic Stroke 55
Oxidative stress inhibits IFN-α-induced antiviral gene expression by blocking the JAK-STAT pathway 54
HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke 54
The POU-domain transcription factor Oct-6/POU3F1 as a regulator of cellular response to genotoxic stress 54
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 54
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 54
Inflammation and prostate cancer 53
Immunological and non-immunological mechanisms of allergic diseases in the elderly: Biological and clinical characteristics 53
Editorial: pharmacotherapy and evidence-based medicine in allergy and clinical immunology-2025 updates and perspectives 52
Transcriptomic in allergy–statistical recommendations 52
Editorial: pharmacotherapy and evidence-based medicine 52
Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms 52
HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection 52
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 52
Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis 52
The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans 51
The effect of allergen immunotherapy in the onset of new sensitizations: a meta-analysis 51
IR (index of reactivity)-house dust mite sublingual immunotherapy liquid formulation for allergic rhinoconjunctivitis: Systematic review and meta-analysis of randomized and nonrandomized studies 50
Sex and Gender in Ageing and Longevity: Highlights From an International Course 50
Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study 50
Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A systematic review and meta-analysis 50
Mediterranean Diet in patients with acute ischemic stroke: Relationships between Mediterranean Diet score, diagnostic subtype, and stroke severity index 49
Totale 8.511
Categoria #
all - tutte 60.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022132 0 0 0 3 17 10 1 6 33 12 7 43
2022/2023443 72 16 13 12 9 22 4 32 234 15 7 7
2023/2024647 11 2 303 3 23 121 13 52 3 9 7 100
2024/20252.465 84 27 61 23 71 327 387 235 671 111 132 336
2025/20265.373 303 390 1.005 1.027 133 177 894 475 402 303 191 73
2026/20271.917 107 538 639 633 0 0 0 0 0 0 0 0
Totale 11.516